Efficacy of repurposed antiviral drugs: Lessons from COVID-19
Top Cited Papers
- 19 February 2022
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 27 (7), 1954-1960
- https://doi.org/10.1016/j.drudis.2022.02.012
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia e Innovación
- España Ministerio de Ciencia e Innovación (PID2019-103955RB-100)
This publication has 67 references indexed in Scilit:
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesJournal of Medicinal Chemistry, 2017
- Approved Antiviral Drugs over the Past 50 YearsClinical Microbiology Reviews, 2016
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common MarmosetThe Journal of Infectious Diseases, 2015
- Favipiravir (T-705), a novel viral RNA polymerase inhibitorAntiviral Research, 2013
- Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected PatientsJournal of Medicinal Chemistry, 2013
- HIV-1 Antiretroviral Drug TherapyCold Spring Harbor Perspectives in Medicine, 2012
- Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is lifeJournal of Antimicrobial Chemotherapy, 2011
- Small molecules targeting severe acute respiratory syndrome human coronavirusProceedings of the National Academy of Sciences of the United States of America, 2004
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999